NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 25-26th, 2025

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

NEXGEL (NASDAQ: NXGL), a leading provider of medical and OTC products specializing in ultra-gentle, high-water-content hydrogels, has announced its participation in the upcoming iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025.

The company's Chief Executive Officer, Adam Levy, will deliver a presentation on Tuesday, March 25th, 2025, at 9:30 a.m. ET. The two-day conference will take place on March 25-26, 2025, and interested parties can access the webcast through the provided link.

Investors seeking one-on-one meetings with Mr. Levy can arrange appointments through iAccess representatives or by contacting KCSA Strategic Communications.

03/13/2025 - 09:00 AM

LANGHORNE, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025 on March 25 and 26, 2025.

iAccess Alpha Virtual Conference Details:
Date: March 25-26, 2025
Presentation Day and Time: Tuesday, March 25th at 9:30 a.m. ET
Webcast: https://www.webcaster4.com/Webcast/Page/3083/52115

To schedule a one-on-one investor meeting with Mr. Levy, please contact your representatives at iAccess or email KCSA Strategic Communications at NEXGEL@KCSA.Com.

About NEXGEL, Inc.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal^®, Hexagels^®, Turfguard^®, Kenkoderm^® and Silly George^®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contacts:

Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
NEXGEL@KCSA.com

FAQ

When is NXGL presenting at the iAccess Alpha Virtual Conference 2025?

NEXGEL (NXGL) will present on Tuesday, March 25th, 2025, at 9:30 a.m. ET during the iAccess Alpha Virtual Best Ideas Spring Investment Conference.

How can investors attend NXGL's presentation at the iAccess Conference?

Investors can access NEXGEL's presentation through the webcast link: https://www.webcaster4.com/Webcast/Page/3083/52115

How can investors schedule one-on-one meetings with NXGL's CEO?

Investors can schedule meetings with CEO Adam Levy through iAccess representatives or by emailing KCSA Strategic Communications at NEXGEL@KCSA.Com

What products does NXGL specialize in?

NEXGEL specializes in ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, offering both medical and over-the-counter (OTC) products.